Sunday, 4 October 2026European Markets

BASSAC, MELEXIS, Another 2 Companies Have A High Estimated Dividend Yield

Loading stream...

(vianews) - bassac (bass.pa), melexis (mele.br), spbk1 ringerike (ring.ol) have the highest dividend yield stocks on this list.

financial asset forward dividend yield updated (est)
bassac (bass.pa) 5% 2023-05-04 07:45:20
melexis (mele.br) 4.7% 2023-05-04 07:15:41
spbk1 ringerike (ring.ol) 3.99% 2023-05-04 07:34:20
selectirente (seler.pa) 3.64% 2023-04-30 08:01:36

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. bassac (bass.pa)

5% foward dividend yield

bassac's last close was €50.20, 29.49% under its 52-week high of €71.20. intraday change was -0.4%.

bassac société anonyme operates as a real estate development company primarily in france, germany, and spain. it offers residential houses and apartments, as well as prefabricated garages and land. the company was incorporated in 1972 and is headquartered in boulogne-billancourt, france. as of december 31, 2021, bassac société anonyme operates as a subsidiary of premier investissement sas.

earnings per share

as for profitability, bassac has a trailing twelve months eps of €9.59.

pe ratio

bassac has a trailing twelve months price to earnings ratio of 5.19. meaning, the purchaser of the share is investing €5.19 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.33%.

more news about bassac.

2. melexis (mele.br)

4.7% foward dividend yield

melexis's last close was €86.75, 18.85% below its 52-week high of €106.90. intraday change was -2.88%.

melexis nv designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in europe, the middle-east, africa, the asia pacific, and north and latin america. the company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ics. it also offers embedded motor driver, fan and pump, led, and pre driver ics; and lin transceiver, can transceiver, rfid transceiver nfc sensor tag ics. the company was founded in 1988 and is headquartered in ieper, belgium. melexis nv is a subsidiary of xtrion n.v.

earnings per share

as for profitability, melexis has a trailing twelve months eps of €4.57.

pe ratio

melexis has a trailing twelve months price to earnings ratio of 18.44. meaning, the purchaser of the share is investing €18.44 for every euro of annual earnings.

sales growth

melexis's sales growth is 16.8% for the present quarter and 10.3% for the next.

volume

today's last reported volume for melexis is 18531 which is 41.01% below its average volume of 31416.

volatility

melexis's last week, last month's, and last quarter's current intraday variation average was a positive 0.23%, a negative 0.84%, and a positive 1.64%.

melexis's highest amplitude of average volatility was 1.33% (last week), 1.81% (last month), and 1.64% (last quarter).

earnings before interest, taxes, depreciation, and amortization

melexis's ebitda is 3.76.

more news about melexis.

3. spbk1 ringerike (ring.ol)

3.99% foward dividend yield

spbk1 ringerike's last close was kr324.00, 5.81% under its 52-week high of kr344.00. intraday change was -4.14%.

sparebank 1 ringerike hadeland provides various banking products and services to private and corporate customers in norway. the company offers saving, current, deposit, and currency accounts; vehicle, house and travel, and animal insurance products, as well as life, child, disability, critical illness, accident, health, and business and personal insurance products; mobile and online banking services; and debit and credit cards. it also provides mortgages; car, boat, and other vehicles; consumer and other loans; and bank guarantees, corporate and construction loans, liquidity loans with a government guarantee, and operating credit for agriculture, as well as factoring, leasing, and overdraft services. in addition, the company offers services for buying and selling property; accounting services; pension products; and savings and investment products. the company was founded in 1833 and is based in hønefoss, norway.

earnings per share

as for profitability, spbk1 ringerike has a trailing twelve months eps of kr25.17.

pe ratio

spbk1 ringerike has a trailing twelve months price to earnings ratio of 12.87. meaning, the purchaser of the share is investing kr12.87 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.9%.

more news about spbk1 ringerike.

4. selectirente (seler.pa)

3.64% foward dividend yield

selectirente's last close was €100.00, 0.99% under its 52-week high of €101.00. intraday change was 0%.

selectirente is a public real estate fund managed by sofidy. it invests in city center and suburb commercial properties, which should be located close to shopping malls. it primarily acquires properties in france. as of march 29, 2019, selectirente operates as a subsidiary of tikehau capital.

earnings per share

as for profitability, selectirente has a trailing twelve months eps of €5.56.

pe ratio

selectirente has a trailing twelve months price to earnings ratio of 17.99. meaning, the purchaser of the share is investing €17.99 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.59%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on jun 10, 2022, the estimated forward annual dividend rate is 3.6 and the estimated forward annual dividend yield is 3.64%.

more news about selectirente.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com